Activity Overview
This educational activity is an archive of the live conference held from February 26, 2026, through February 28, 2026.
Target Audience
This educational activity is directed toward community-based hematologists and medical oncologists, as well as fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
Upon participation in this activity, learners will be better able to:
- Evaluate recent clinical trial results on approved and emerging therapeutic approaches for patients with hematologic disorders
- Describe best practices for mitigating and managing treatment-related adverse events in patients with hematologic disorders